A Multi-Center Study of High Dose Aldesleukin (Interleuk

  • Rudrapatna, Venkatesh K (PI)

Project: Research project

Project Details

Description

A Multi-Center Study of High Dose Aldesleukin (Interleukin-2)+ Vemurafenib Therapy in Patients with BRAF v600 mutation positive metastatic melanoma.
StatusFinished
Effective start/end date5/1/1211/30/16

Funding

  • Prometheus Laboratories, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.